Lessons learned from the CRUSADE National Quality Improvement Initiative

Eric D. Peterson; David Z. Bynum; Matthew T. Roe

doi:10.1007/s11886-008-0046-9

Lessons learned from the CRUSADE National Quality Improvement Initiative

Eric D. Peterson, David Z. Bynum, Matthew T. Roe

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Abstract

The CRUSADE National Quality Improvement Initiative was created to track national care patterns, facilitate process improvement, and improve patient outcomes among patients with acute coronary syndromes (ACS). CRUSADE found that patients in community practice were sicker than those in randomized clinical trials and often failed to receive evidence-based therapies. Dosing regimens of antithrombotic therapy were also suboptimal, raising safety concerns. Over time, guideline adherence and dosing regimens of ACS patients have improved dramatically, leading to significantly improved outcomes. Ongoing quality improvement efforts will be needed to further improve evidence-based and personalized care of patients with ACS.

Original language	English (US)
Pages (from-to)	285-290
Number of pages	6
Journal	Current Cardiology Reports
Volume	10
Issue number	4
DOIs	https://doi.org/10.1007/s11886-008-0046-9
State	Published - 2008
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s11886-008-0046-9

Cite this

@article{cad73f6de5d6481e90f0c0512afb38b0,

title = "Lessons learned from the CRUSADE National Quality Improvement Initiative",

abstract = "The CRUSADE National Quality Improvement Initiative was created to track national care patterns, facilitate process improvement, and improve patient outcomes among patients with acute coronary syndromes (ACS). CRUSADE found that patients in community practice were sicker than those in randomized clinical trials and often failed to receive evidence-based therapies. Dosing regimens of antithrombotic therapy were also suboptimal, raising safety concerns. Over time, guideline adherence and dosing regimens of ACS patients have improved dramatically, leading to significantly improved outcomes. Ongoing quality improvement efforts will be needed to further improve evidence-based and personalized care of patients with ACS.",

author = "Peterson, {Eric D.} and Bynum, {David Z.} and Roe, {Matthew T.}",

note = "Funding Information: Eric D. Peterson receives research grants from Bristol-Myers Squibb, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, Bristol-Myers Squibb/Merck, and Schering Plough Corporation. Matthew T. Roe is on the speakers{\textquoteright} bureau for Bristol-Myers Squibb/Sanofi-Aventis Pharmaceuticals Partnership and Schering-Plough. He receives research grants from Bristol-Myers Squibb/Sanofi-Aventis Pharmaceuticals Partnership and Schering Plough. He also consults and is on advisory boards for Schering-Plough. No other potential conflicts of interest relevant to this article were reported.",

year = "2008",

doi = "10.1007/s11886-008-0046-9",

language = "English (US)",

volume = "10",

pages = "285--290",

journal = "Current Cardiology Reports",

issn = "1523-3782",

publisher = "Current Medicine Group",

number = "4",

}

TY - JOUR

T1 - Lessons learned from the CRUSADE National Quality Improvement Initiative

AU - Peterson, Eric D.

AU - Bynum, David Z.

AU - Roe, Matthew T.

N1 - Funding Information: Eric D. Peterson receives research grants from Bristol-Myers Squibb, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, Bristol-Myers Squibb/Merck, and Schering Plough Corporation. Matthew T. Roe is on the speakers’ bureau for Bristol-Myers Squibb/Sanofi-Aventis Pharmaceuticals Partnership and Schering-Plough. He receives research grants from Bristol-Myers Squibb/Sanofi-Aventis Pharmaceuticals Partnership and Schering Plough. He also consults and is on advisory boards for Schering-Plough. No other potential conflicts of interest relevant to this article were reported.

PY - 2008

Y1 - 2008

N2 - The CRUSADE National Quality Improvement Initiative was created to track national care patterns, facilitate process improvement, and improve patient outcomes among patients with acute coronary syndromes (ACS). CRUSADE found that patients in community practice were sicker than those in randomized clinical trials and often failed to receive evidence-based therapies. Dosing regimens of antithrombotic therapy were also suboptimal, raising safety concerns. Over time, guideline adherence and dosing regimens of ACS patients have improved dramatically, leading to significantly improved outcomes. Ongoing quality improvement efforts will be needed to further improve evidence-based and personalized care of patients with ACS.

AB - The CRUSADE National Quality Improvement Initiative was created to track national care patterns, facilitate process improvement, and improve patient outcomes among patients with acute coronary syndromes (ACS). CRUSADE found that patients in community practice were sicker than those in randomized clinical trials and often failed to receive evidence-based therapies. Dosing regimens of antithrombotic therapy were also suboptimal, raising safety concerns. Over time, guideline adherence and dosing regimens of ACS patients have improved dramatically, leading to significantly improved outcomes. Ongoing quality improvement efforts will be needed to further improve evidence-based and personalized care of patients with ACS.

UR - http://www.scopus.com/inward/record.url?scp=54449084190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54449084190&partnerID=8YFLogxK

U2 - 10.1007/s11886-008-0046-9

DO - 10.1007/s11886-008-0046-9

M3 - Review article

C2 - 18611362

AN - SCOPUS:54449084190

SN - 1523-3782

VL - 10

SP - 285

EP - 290

JO - Current Cardiology Reports

JF - Current Cardiology Reports

IS - 4

ER -

Lessons learned from the CRUSADE National Quality Improvement Initiative

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this